Suxia Luo
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 65
- Cancer Immunotherapy and Biomarkers 20
- Lung Cancer Research Studies 11
- HER2/EGFR in Cancer Research 8
- Colorectal Cancer Treatments and Studies 8
-
- Gastric Cancer Management and Outcomes 20
- Ferroptosis and cancer prognosis 8
- Co-authors
- Kongming Wu (16 shared papers)Ming Yi (16 shared papers)Linping Xu (4 shared papers)Shuang Qin (3 shared papers)Shengnan Yu (1 shared paper)Mengke Niu (7 shared papers)Anping Li (6 shared papers)Bing Dong (6 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Annals of Translational Medicine (7 papers)Annals of Oncology (6 papers)Journal of Hematology & Oncology (5 papers)Experimental Hematology and Oncology (4 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Suxia Luo
102 papers receiving 3.5k citations
Suxia Luo's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 2.0k
- Cancer Research 745
- Immunology 993
- Pulmonary and Respiratory Medicine 793
- Molecular Biology 1.3k
Countries citing papers authored by Suxia Luo
This map shows the geographic impact of Suxia Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxia Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxia Luo more than expected).
Fields of papers citing papers by Suxia Luo
This network shows the impact of papers produced by Suxia Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxia Luo. The network helps show where Suxia Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Suxia Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 Hit paper breakdown → | 2019 | 858 |
| 2 | Regulation of PD-L1 expression in the tumor microenvironment Hit paper breakdown → | 2021 | 440 |
| 3 | 2020 | 168 | |
| 4 | 2021 | 162 | |
| 5 | 2020 | 135 | |
| 6 | 2019 | 106 | |
| 7 | 2021 | 101 | |
| 8 | 2021 | 96 | |
| 9 | 2021 | 91 | |
| 10 | 2019 | 87 | |
| 11 | 2014 | 82 | |
| 12 | 2020 | 82 | |
| 13 | 2018 | 81 | |
| 14 | 2021 | 75 | |
| 15 | 2021 | 74 | |
| 16 | 2021 | 70 | |
| 17 | 2021 | 67 | |
| 18 | 2022 | 40 | |
| 19 | 2020 | 34 | |
| 20 | 2018 | 34 |
About Suxia Luo
Suxia Luo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 108 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Gastric Cancer Management and Outcomes (20 papers), Esophageal Cancer Research and Treatment (12 papers), Lung Cancer Research Studies (11 papers), HER2/EGFR in Cancer Research (8 papers), Ferroptosis and cancer prognosis (8 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastrointestinal Tumor Research and Treatment (6 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (745 citations), Immunology (993 citations), Pulmonary and Respiratory Medicine (793 citations) and Molecular Biology (1.3k citations). Suxia Luo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Kongming Wu, Ming Yi, Linping Xu, Shuang Qin, Shengnan Yu, Mengke Niu, Anping Li, Bing Dong, Qian Chu and Ying Jiao. Their work appears in journals such as Journal of Clinical Oncology, Annals of Translational Medicine, Annals of Oncology, Journal of Hematology & Oncology and Experimental Hematology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.